BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 10658234)

  • 1. Trends of generic substitution in community pharmacies.
    Suh DC
    Pharm World Sci; 1999 Dec; 21(6):260-5. PubMed ID: 10658234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 'Generic substitution' in New Jersey, 1979-87.
    Culkin TT; Mendell S
    Am Pharm; 1989 Feb; NS29(2):25-30. PubMed ID: 2648782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring generic drug use behavior: the role of prescribers and pharmacists in the opportunity for generic drug use and generic substitution.
    Mott DA; Cline RR
    Med Care; 2002 Aug; 40(8):662-74. PubMed ID: 12187180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of generic substitution: The role of psychological, sociodemographic, and contextual factors.
    Drozdowska A; Hermanowski T
    Res Social Adm Pharm; 2016; 12(1):119-129. PubMed ID: 25935316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perceptions of pharmacists and physicians on generic substitution in a financial crisis context in Northwestern Spain: A qualitative study.
    Mondelo-García C; Mendoza E; Movilla-Fernández MJ; Coronado C
    Health Policy; 2018 Dec; 122(12):1316-1325. PubMed ID: 30201184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analyzing generic and branded substitution patterns in the Netherlands using prescription data.
    Pechlivanoglou P; van der Veen WJ; Bos JH; Postma MJ
    BMC Health Serv Res; 2011 Apr; 11():89. PubMed ID: 21524312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacists' views and reported practices in relation to a new generic drug substitution policy in Lebanon: a mixed methods study.
    El-Jardali F; Fadlallah R; Morsi RZ; Hemadi N; Al-Gibbawi M; Haj M; Khalil S; Saklawi Y; Jamal D; Akl EA
    Implement Sci; 2017 Feb; 12(1):23. PubMed ID: 28212657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What are the obstacles to generic substitution? An assessment of the behaviour of prescribers, patients and pharmacies during the first year of generic substitution in Sweden.
    Andersson K; Sonesson C; Petzold M; Carlsten A; Lönnroth K
    Pharmacoepidemiol Drug Saf; 2005 May; 14(5):341-8. PubMed ID: 15624198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Customers' and physicians' opinions of and experiences with generic substitution during the first year in Finland.
    Heikkilä R; Mäntyselkä P; Hartikainen-Herranen K; Ahonen R
    Health Policy; 2007 Aug; 82(3):366-74. PubMed ID: 17141355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generic drug prescriptions following hospital discharge: a prospective study in France.
    Chu C; Rudant E; Bonvalet M; Agostini H; Cavalié P; Bonhomme-Faivre L; Frenkiel J; Taillandier J; Boissonnas A; Vittecoq D; Wyplosz B
    Eur J Intern Med; 2011 Oct; 22(5):e45-9. PubMed ID: 21925042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential savings from generic prescribing and generic substitution in South Africa.
    Karim SS; Pillai G; Ziqubu-Page TT; Cassimjee MH; Morar MS
    Health Policy Plan; 1996 Jun; 11(2):198-205. PubMed ID: 10158460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interventions performed by New Zealand community pharmacists while dispensing prescription medications.
    Braund R; Furlan HM; George K; Havell MM; Murphy JL; West MK
    Pharm World Sci; 2010 Feb; 32(1):22-5. PubMed ID: 19882232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A nationwide survey exploring physicians' and pharmacists' knowledge, awareness and perceptions regarding generic medicines in China.
    Qu J; Zuo W; Took RL; Schafermeyer KW; Lukas S; Wang S; Du L; Liu X; Gao Y; Li J; Pan H; Du X; Mei D; Zhang B
    BMC Health Serv Res; 2022 Aug; 22(1):1069. PubMed ID: 35987631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating pharmacists' views, knowledge, and perception regarding generic medicines in New Zealand.
    Babar ZU; Grover P; Stewart J; Hogg M; Short L; Seo HG; Rew A
    Res Social Adm Pharm; 2011 Sep; 7(3):294-305. PubMed ID: 21272551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of competition on prescription-drug-product substitution.
    Kralewski JE; Pitt L; Dowd B
    N Engl J Med; 1983 Jul; 309(4):213-6. PubMed ID: 6866035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of state-level pharmacist regulations on generic substitution of prescription drugs.
    Song Y; Barthold D
    Health Econ; 2018 Nov; 27(11):1717-1737. PubMed ID: 29992674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pilot study on generic medicine substitution practices among community pharmacists in the State of Penang, Malaysia.
    Ping CC; Bahari MB; Hassali MA
    Pharmacoepidemiol Drug Saf; 2008 Jan; 17(1):82-9. PubMed ID: 17879323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perceptions and behaviors of patients and pharmacists towards generic drug substitution in Lebanon.
    Saleh S; Abou Samra C; Jleilaty S; Constantin J; El Arnaout N; Dimassi H; Al-Bittar D
    Int J Clin Pharm; 2017 Oct; 39(5):1101-1109. PubMed ID: 28823020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of generic switching on concerns about medicine and non-persistence among Danish adults in a general practice setting.
    Rathe JØ
    Dan Med J; 2015 Oct; 62(10):B5148. PubMed ID: 26441397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Third-party reimbursement for generic prescription drugs: The prevalence of below-cost reimbursement in an environment of maximum allowable cost-based reimbursement.
    Murry L; Gerleman B; Urick B; Urmie J
    J Am Pharm Assoc (2003); 2018; 58(4):421-425. PubMed ID: 29861152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.